Assessment of Ovarian Reserve in Women With Rheumatologic Diseases

The Influence of Rheumatologic Diseases on Fertility and Ovarian Reserve

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02273869

Enrollment

300

Registered

2014-10-24

Start date

2014-12-31

Completion date

2018-04-30

Last updated

2014-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Ovarian Reserve, Rheumatologic Diseases

Brief summary

Our infertility unit has started a clinic for women with rheumatological diseases. those women are prone to infertility problems and it might be due to their illness or cytotoxic treatment . In our study we are going to observe the effect of their disease on ovarian reserve. we will assess it by using intravaginal sonography and blood test such as hormonal profile and anti-mullerian hormone (AMH).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

12 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Rheumatologic disease

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
hormone profile	4 years	Assessment of ovarian function using hormone profile and AMH levels in serum, in women with rheumatologic disease.
antral follicular count	4 years	we will use sonography to assess the antral follicular count as a parameter for ovarian reserve in women with rheumatologic disease.

Countries

Israel

Contacts

Primary ContactEinat Haikin HErzberger, M.D

einatcha1@yahoo.com972-506728987

Outcome results